Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-07

Clinical Trial Update: Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial update showing results for sunitinib in unresectable kidney cancer (renal cell carcinoma); results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sutent (sunitinib)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-01-07